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Abstract
Purpose To compare the postoperative outcomes and compli-
cations of glaucoma drainage device (GDD) surgery in
pediatric (<18 years old) and adult patients.
Methods Retrospective, comparative study including all pa-
tients who underwent Baervedlt or Molteno device surgery by
the same surgeon. Success criteria included postoperative in-
traocular pressure (IOP) between 6 and 21 mmHg and a 20%
reduction from baseline.
Results Fifty-two children (69 eyes) and 130 adults (145 eyes)
were included. Mean IOP and number of medications were
significantly reduced postoperatively in both groups. Overall
failure rate was similar in children and adults. However, GDD
failed earlier in adults than in children. Hypotony was the
most common complication in both groups in the first
6 months postoperatively. Later on, bleb encapsulation was
more frequent in children, while corneal decompensation
tended to be more frequent and occurred earlier in adults.
Children also had a higher rate of infectious endophthalmitis
and required tube repositioning more frequently than adults.
Conclusions GDD surgery presents different postoperative
challenges in children and adults, and the surgeon should
remain vigilant for complications throughout the postopera-
tive period, especially for signs of endophthalmitis or bleb
encapsulation in pediatric patients. On the other hand, adults
may be more prone to early corneal decompensation.
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Introduction
Glaucoma drainage devices (GDDs) have been developed as
an additional option to trabeculectomy in the surgical manage-
ment of refractory or complex glaucoma. Their use has been
growing in popularity in recent years to also include cases of
simple open-angle glaucoma. The Tube vs. Trabeculectomy
Study, a randomized clinical trial on glaucoma patients with
previous trabeculectomy and/or cataract surgery, showed a
superior 5-year success rate for GDD compared to augmented
trabeculectomy with a lower reoperation rate and a similar
safety profile [1, 2].
GDDs are used in the surgical management of adult as well
as pediatric glaucoma. Compared with adults, children have
smaller eyes with highly elastic scleral tissue, which frequent-
ly makes implantation of the GDD challenging. In addition,
differences in the type of glaucoma between children and
adults may affect the surgical outcome of GDD, as primary
congenital and developmental glaucoma predominate in
children, whereas chronic open-angle glaucoma is the
predominant type of glaucoma in adults.
Although there are several reports in the literature on the
safety and efficacy of various types of GDD implantation in
children and adults, there is no comparative study on the
success and complications of GDD between these age groups.
We reported in our previous study on the long-term outcomes
and complications of GDD surgery in children in comparison
to the existing literature [3]. The purpose of this study was to
compare the outcomes and complications of GDD surgery in
our pediatric series with adult patients coming from the same
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population who were operated upon by the same surgeon at a
tertiary glaucoma referral center.
Methods
This was a retrospective, comparative study including all
glaucoma patients who underwent GDD surgery by the
same surgeon (V.S.) at Birmingham and Midland Eye
Centre during the period from January 1, 2004 to
December 31, 2011. Data were retrieved from the case
notes. The parameters recorded included best corrected
visual acuity (BCVA), intraocular pressure (IOP) and
antiglaucoma medications at the last preoperative clinic
visit and at 3, 6 and 12 months postoperatively and every
6 months thereafter. Any complications and further proce-
dures throughout the follow-up period were also recorded.
Data collection was censored at the last clinic visit or at
the time of failure. For patients who were lost to follow-
up, data collection was censored at their last clinic visit.
The study was approved by the local Research Ethics
Committee (reference: 12/WM/0158).
The most common GDD implanted was the Baerveldt
implant (surface area: 250 mm2 or 350 mm2) and less
commonly the Molteno single-plate device (Table 1).
The choice of GDD was determined by the surgeon after
careful evaluation of the risk of postoperative hypotony,
taking into account the type of glaucoma and any previ-
ous surgical or laser interventions as well as the accessi-
bility of the sub-Tenon’s space for placement of the plate.
The surgical technique was described in a previous report
[3]. In brief, the conjunctiva and Tenon’s fascia were dis-
sected in the superior temporal quadrant. Mitomycin C
(MMC; 0.2–0.4 mg/ml) was applied on the equatorial
sclera under the sub-Tenon pocket for 3–5 min. The plate
was placed 8–10 mm posterior to the limbus and secured
on the sclera with 7–0 polypropylene sutures. A 3–0 poly-
amide (Supramid, S. Jackson Inc., Alexandria, VA, USA)
stent suture was introduced in the tube to avoid over-
drainage. The tube was trimmed in a bevel-up fashion
so that it would extend 1–2 mm beyond the limbus and
was inserted into the anterior chamber through a scleral
track made with a 25-gauge needle 2 mm posterior to the
limbus. The tube was secured on the sclera with
interrupted 9–0 nylon sutures and was ligated with a 6–
0 polyglactin (dissolvable) suture. A 0.5-mm-long venting
slit was made along the tube in all cases to allow for a
small amount of leakage until the ligation suture dis-
solved, normally in about 6 week. Ethanol-preserved do-
nor sclera was used to cover the tube near the limbus and
was secured on host sclera with interrupted 9–0 nylon
sutures. Tenon’s fascia and conjunctiva were closed with
running 8–0 polyglactin sutures. Antibiotics and steroids
were given intracamerally along with a supplemental
orbital floor injection of a 50:50 mixture of 40 mg triam-
cinolone with 0.5% bupivacaine. The postoperative
regimen included topical antibiotics and a tapering course
of topical corticosteroid for 3 months. In addition, a 3-
week tapering course of oral prednisolone (a commencing
dose of 0.5 mg/kg) and a non-steroidal anti-inflammatory
agent, e.g., ibuprofen, were routinely prescribed for pa-
tients aged 5 years or more.
Success was defined as postoperative IOP from 6 to
21 mmHg and a reduction in IOP of at least 20% from preop-
erative levels without (complete success) or with (qualified
success) topical and/or oral antiglaucoma medications.
Additional criteria included no devastating vision loss (i.e.,
loss of light perception) and no need for further glaucoma
surgery including cyclodestructive procedures. However, in-
terventions to improve function of the GDD (such as removal
of stent sutures, bleb needling and repositioning or shortening
of the tube) were allowed. Hypotony was defined as
IOP < 6 mmHg in at least two consecutive clinic visits or in
the presence of hypotony complications (e.g., shallow anterior
chamber and/or choroidal detachment). Bleb encapsulation
was identified in the case notes as the description of a thick
fibrous capsule around the plate restricting aqueous outflow
and resulting in an IOP increase compared to that observed at
the previous visit. Corneal decompensation was defined as
persistent localized or generalized corneal edema in at least
two consecutive visits. Endophthalmitis was defined as an
inflammatory reaction involving both the anterior segment
and the vitreal cavity.
Statistical analysis was performed using SPSS v16.0 (SPSS
Inc., Chicago, IL, USA), and a P value of 0.05 was used to
denote statistical significance. As data were not found to be
normally distributed, non-parametric tests were used, namely
theMann–Whitney test for numerical variables, the chi-square
test or Fisher’s exact test for frequencies and the Wilcoxon
signed-ranks test for paired variables. Comparative survival
analysis was performed using the Kaplan–Meier log-rank test.
Results
Fifty-two children (69 eyes) aged less than 18 years at the time
of GDD surgery and 130 adults (145 eyes) were included in
the study. Mean age at surgery was 8.3 ± 5.1 years old for
pediatric patients and 50.3 ± 16.5 years old for adult patients.
The demographic and preoperative characteristics of the two
age groups are shown comparatively in Table 1.
Patients were mostly Caucasian in both groups; however,
South Asian ethnicity was more frequent in pediatric patients
and Afro-Caribbean ethnicity was more prevalent in adults.
As was expected, type of glaucoma differed between the
groups, congenital-developmental and aphakic glaucoma
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Table 1 Baseline characteristics
of patients Pediatric group Adult group P value
N % N %
Age (years)
Mean (SD) 8.3 (5.1) 50.3 (16.5) <0.001*
Sex 0.184
Male 26 50.0 80 61.5
Female 26 50.0 50 38.5
Ethnicity 0.140
Caucasian 30 57.7 86 66.2
Non-Caucasian 22 42.3 44 33.8
Eye 0.618
Right 32 46.4 62 42.8
Left 37 53.6 83 57.2
Type of glaucoma <0.001*
OAG 0 0.0 35 26.9
Congenital 10 19.2 5 3.8
ACG 0 0.0 8 6.2
Uveitic 11 21.2 31 23.8
Aphakic 16 30.8 15 11.5
Ant. segment dysgenesis/aniridic 8 15.4 2 1.5
Othera 7 13.5 34 26.2
Family history of glaucoma 0.534
Yes 13 25.0 27 20.8
No/unknown 39 75.0 103 79.2
Previous glaucoma surgery 0.810
Yes 34 49.2 74 51.0
No 35 50.8 71 49.0
Lens status 0.188
Phakic 39 56.5 68 46.9
Non-phakic (pseudophakic or aphakic) 30 43.5 77 53.1
GDD type 0.08
Molteno 16 23.2 20 13.8
Baerveldt (250 mm2 or 350 mm2 model) 53 76.8 125 86.2
MMC use 0.589
Yes 60 86.9 122 84.1
No 9 13.1 23 15.9
Preoperative IOP (mmHg)
Mean (SD) 29.4 (8.9) 28.1 (8.8) 0.097
No. of preop. antiglaucoma medications
Mean (SD) 3.8 (1.2) 3.6 (1.1) 0.177
Preoperative VA (logMAR)
Mean (SD) 0.79 (0.60) 0.70 (0.75) 0.062
OAG: open-angle glaucoma (includes primary OAG, pseudoexfoliative, pigmentary
juvenile OAG). ACG: angle-closure glaucoma (primary or secondary)
a Includes: mixed mechanism, phacomatose-related, neovascular, traumatic, secondary
to keratoplasty/retinal detachment surgery, etc.
*Denotes statistical significance
Mann–Whitney test, chi-square or Fisher’s exact test were used where appropriate
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being more frequent in children as opposed to chronic open-
angle glaucoma and glaucoma from other causes, which
prevailed in the adult group. Most patients were phakic at
the time of surgery; however, most of the non-phakic children
were aphakic, whereas most of the non-phakic adults were
pseudophakic. No statistically significant differences were
noted with regard to preoperative IOP, BCVA or the number
of antiglaucoma medications. Approximately half of the pa-
tients in each group had undergone at least one glaucoma
procedure prior to GDD surgery. Previous glaucoma surgeries
included goniotomy, trabeculotomy, trabeculectomy, GDD
implantation and cyclophotocoagulation. The previous sur-
gery profile was slightly different between children and adults,
although trabeculectomy was the most prevalent surgical
procedure in both groups. No patient in the adult group had
undergone goniotomy or trabeculotomy.
The Baerveldt implant was the most commonGDD in both
groups (Table 1). However, most of the children received the
implant with a surface area of 250 mm2 (38 out of 69 eyes),
whereas most of the adults had the 350-mm2 implant (92 out
of 145 eyes).
Themean ± SD length of follow-upwas 45.7 ± 25.2months
for pediatric patients and 32.6 ± 22.2 months for adults
(P < 0.001, Mann–Whitney test). At the last follow-up or
pre-censor visit, mean ± SD IOP was 15.5 ± 8.4 mmHg in
children and 14.9 ± 6.7 mmHg in adults, whereas the mean
± SD number of antiglaucoma medications was 0.7 ± 1.1 and
0.4 ± 0.9, respectively. Mean IOP and mean number of med-
ications were significantly reduced from baseline in both age
groups (P < 0.001, Wilcoxon signed-ranks test) at all time-
points. Moreover, IOP was similar between age groups up to
7 years postoperatively; the same was true for the number of
medications.
Final postoperative mean ± SD BCVA was 0.74 ± 0.59
logMAR in pediatric patients and was not significantly differ-
ent from preoperative levels, whereas in adults, it was 0.93
± 0.93 logMAR and was significantly worse than preoperative
measurements (P < 0.001, Wilcoxon signed-ranks test).
The cumulative probabilities of complete and qualified
success did not differ significantly between age groups
(Table 2). Survival of GDD was also plotted on Kaplan–
Meier curves (Fig. 1, showing curves for qualified success).
Throughout the follow-up period, 23 (33.3%) pediatric and
42 (28.9%) adult cases were classified as failures. The distri-
bution of reasons for GDD failure was marginally different
between children and adults (Table 3). Four patients in each
group had their GDD removed. In the pediatric group, all
cases were associated with endophthalmitis. In adults, remov-
al of the GDDwas due to corneal decompensation in one case,
phthisis in one case and enucleation of the eye for reasons
unrelated to GDD in the other two cases.
Although failure rates were similar between groups, medi-
an time to establishment of failure was significantly longer in
children (37.3 months) than in adults (20.3 months), thus
denoting that GDD may fail earlier in adults (P = 0.032,
Mann–Whitney test).
In the first 6 months postoperatively, hypotony was the
most frequent complication in both groups. After 6 months,
cataract and bleb encapsulation were the most prevalent
complications in the pediatric group, whereas corneal decom-
pensation prevailed in adults (Table 4).
Compared with adults, pediatric patients exhibited more
frequent bleb encapsulation during the late postoperative
period (P = 0.001). Therefore, children also required bleb nee-
dling or bleb revision more frequently than adults (P = 0.007),
although in one adult case, bleb revision was performed in
order to excise a retention cyst. Furthermore, significantly
more pediatric patients required tube repositioning or shorten-
ing procedures to correct the intraocular position of the tube,
especially in cases where the tube progressively approximated
or actually touched the corneal endothelium (P < 0.001).
Four pediatric patients developed endophthalmitis as
opposed to two adult patients (P = 0.08). In two out of four
pediatric cases of endophthalmitis, culture yielded positive
results. The other two cases, although culture-negative, exhib-
ited highly suspicious clinical signs of infective endophthal-
mitis, including hypopyon and vitritis. In contrast, both adult
cases were sterile.
A higher proportion of adults developed corneal decom-
pensation during follow-up, but this difference did not reach
statistical significance (Table 4). However, the cornea seemed
to decompensate earlier in adults as compared to children
(median time of 18 months in adults versus 48.5 months in
children, P = 0.004, Mann–Whitney test).
Although cataracts developed in a higher proportion of
pediatric patients than adults, this difference did not reach
statistical significance. Median (range) time to cataract
development was 9 (3–54) months in children and 6 (2–30)
months in adults (P = 0.56, Mann–Whitney test).
Hypotony was slightly more frequent in children, but this
difference was not statistically significant. In a significant
minority of cases (22.2% in children and 31.3% in adults),
hypotony occurred after manipulation (adjustment or remov-
al) of the stent suture or laser lysis of the ligating suture (and in
one case, after bleb needling) due to inadequate IOP control.
Hypotony was managed with the intracameral injection of a
viscoelastic device and by ligation of the tube in refractory
cases. The mean (SD) number of intracameral injections was
1.8 (1.0) injections in children and 2.6 (1.8) injections in
adults and was marginally different between groups
(P = 0.05, Mann–Whitney test). This difference in the need
for intracameral injection of viscoelastic reflects the fact that
hypotony settled more easily in children, whereas in adults it
was more resistant to management. This may also explain the
trend for more frequent tube tying in the adult group,
especially in the first 6 months postoperatively (Table 4). It
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could be that children had healthier ciliary bodies and aqueous
production and, therefore, were able to recover from hypotony
more efficiently than adults. In fact, 30.3% of adult eyes had
undergone cyclodestructive procedures prior to GDD surgery
as opposed to only 18.8% in children and this may have re-
sulted in a relatively lower capacity of adult eyes to recover
from hypotony via aqueous production.
In the first 6 months postoperatively, significantly more
pediatric patients required adjustment or removal of the
stent suture to improve IOP control (Table 4). However,
the overall rate of stent suture removal or adjustment
throughout the follow-up period was similar between
age groups, and no significant difference was noted in
the median time of stent suture manipulation (5 months
in children, 7 months in adults, P = 0.52, Mann–Whitney
test). Due to the fact that the median time of stent suture
manipulation in adults was shortly after the cut-off time-
point used to separate early from late interventions, we
also compared the rates of stent suture adjustment or re-
moval in the first 12 months. The difference turned out to
be non-significant (53.6% of children vs. 42.7% of adults,
P = 0.14).
Fig. 1 Kaplan–Meier survival
curve for qualified success for
pediatric and adult patients
Table 2 Cumulative






Children Adults Children Adults Children Adults
1 year 95.6 91.4 95.6 93.4 65 123
2 years 92.5 77.3 92.5 81.3 56 77
3 years 78.7 65.6 83.8 73.8 41 51
4 years 64.2 59.7 77.3 69.0 27 35
5 years 59.2 49.9 71.3 62.0 22 21
6 years 41.7 31.0 59.9 45.1 14 10
7 years 24.2 22.3 39.7 32.5 6 4
Survival log-rank test (P value) 0.252 0.185
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Finally, no significant association was found between the
intraoperative use of MMC and late hypotony, bleb encapsu-
lation, stent suture manipulation or endophthalmitis in either
group (Fisher’s exact test). Similarly, IOP at 3 and 5 years
postoperatively did not differ significantly between patients
who had undergone augmented versus non-augmented sur-
gery in either group (Mann–Whitney test).
Discussion
In this study, overall GDD outcomes were similar between
children and adults; however, there was a trend of GDD to
fail earlier in adults, as indicated by the steeper survival curve
in this group (Fig. 1). Although the reasons for this are not
clear, it could be that the differences in the baseline character-
istics of the two age groups affected the outcome. For exam-
ple, the observed differences in the distribution of ethnicities
in the two groups, combined with the inherent differences in
the prevailing types of glaucoma and the slightly different
previous surgical profile, may have had an impact in the nat-
ural history of GDD surgery in this study. Another potential
explanation for the earlier failure of GDD in adults could be
the longer duration of glaucoma medication use in this group;
long-term topical therapy has been associated with an in-
creased pro-inflammatory load in the conjunctiva and has
been identified as a risk factor for failure of glaucoma filtration
surgery. [4] Our success rates fell within a wide range of so-far
published outcomes of GDD surgery. In the literature, success
rates of 58.8–94.7% in children [5–13] and 64.0–91.7% in
adults have been reported [1, 14, 15], thus indicating that
outcomes may vary widely depending on the population stud-
ied and the definition of success. It is noteworthy that in our
study, we used the IOPs at the last preoperative clinic visit as
our baseline IOPs, and this may have underestimated the
average IOPs before surgery, as most patients were on heavy
antiglaucoma medications, particularly oral acetazolamide in
the adult group as we tend to avoid oral acetazolamide in
pediatric group because of the higher risk of potential side
effects in children. This could potentially have skewed our
outcomes towards failure due to failing to meet the 20% IOP
reduction criterion. Indeed, this was the most frequent reason
for classification as failure in the adult group (Table 3). In fact,
if we allowed for an IOP reduction of less than 20% from
baseline, the overall success rate at the last visit would have
been as high as 82.1% in adults (67.6% complete and 14.5%
qualified success) and 73.9% in children (55.1% complete and
18.8% qualified success).
Although no significant differences in the success rates
were found between the two groups, one needs to consider
the possibility of the GDD type affecting the outcome.
Actually, in an ad-hoc analysis, GDD type seemed to influ-
ence the success/failure rate in the pediatric group (significant-
ly higher rate of failure with theMolteno as compared to either
type of the Baerveldt tube, although the sample was small and,
therefore, of limited statistical power), whereas it did not seem
to affect the failure rates in adults. The distribution of the three
GDD types used in this study differed in the two groups and
GDD selection was the result of careful preoperative evalua-
tion and consideration of individual circumstances. In fact, the
choice of GDD type very much depended on the size of the
eye and risk factors for hypotony based on the surgeon’s ex-
perience and preoperative assessment. In younger children,
the smaller eye size and the relatively smaller orbital volume
would make implanting a 350-mm2 plate significantly more
difficult; hence, a GDDwith a smaller plate like the Baerveldt-
250 or Molteno single plate would be technically more suit-
able. Furthermore, in eyes with a prior history of multiple
cyclodestructive procedures or chronic uveitis, the risk of hy-
potony in the postoperative period is higher; therefore, a small
plate size would be safer and more desirable.
Children had a significantly higher rate of bleb encapsula-
tion than adults. This may denote a more aggressive scarring
response of pediatric eyes, despite the intraoperative use of
Table 3 Reasons for failure for
each age group Paediatric group Adult group P value
N % N %
Reasons for failure 0.043*
IOP > 21 mmHg 6 26.1 5 11.9
IOP < 6 mmHg 3 13.0 1 2.4
<20% IOP reduction 5 21.8 17 40.5
Further glaucoma surgery 1 4.3 1 2.4
Cyclodestructive procedures 4 17.4 6 14.3
Loss of light perception 0 0.0 8 19.0
Other (e.g., GDD removal, enucleation) 4 17.4 4 9.5
Total 23 100.0 42 100.0
*Denotes statistical significance (Fisher’s exact test)
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MMC. Previous studies reported a wide range of bleb
encapsulation rates of 3.2–14.3% in children [5, 6, 16] and
2.0–27.1% in adults [2, 17]. These discrepancies may be at-
tributed to variation in the definition of bleb encapsulation and
differences in patient characteristics. Unlike trabeculectomy, it
is our experience that bleb needling after GDD surgery does
not offer sustainable improvement in IOP control; instead, it
may cause acute hypotony complications and then exacerba-
tion of bleb encapsulation that increases the risks of failure. In
fact, 7 out of 11 children and 3 out of 6 adults that underwent
bleb needling or bleb revision were ultimately classified as
failures.
In our study, about 6% of pediatric patients suffered either
definite or strongly suspected infectious endophthalmitis and
had their GDD removed. In our previous study [3], we
discussed this high incidence of endophthalmitis in relation
to the published literature. In contrast, no adult patient devel-
oped infectious endophthalmitis, although there were two
Table 4 Postoperative
complications and procedures for
each age group
Pediatric group Adult group P value
N % N %
Complications (within first 6 months)
Hypotony 27 39.1 53 36.6 0.716
Choroidal effusion/detachment 15 21.7 39 26.9 0.417
Uveitis 6 8.7 13 9.0 0.948
Bleb encapsulation 1 1.4 1 0.7 0.542
Tube retraction 0 0.0 1 0.7 1.000
Corneal decompensation 0 0.0 4 2.8 0.308
Endophthalmitis 2 2.9 0 0.0 0.103
Retinal detachment 1 1.4 1 0.7 0.542
Cataracta 8 20.5 10 14.7 0.440
Postoperative procedures (within first 6 months)
Intracameral injection of viscoelastic 27 39.1 48 33.1 0.388
Tying tube off 4 5.8 20 13.8 0.083
Removal/adjustment of stent suture 29 42.0 38 26.2 0.020*
Tube shortening/repositioning 2 2.9 4 2.8 1.000
Bleb needling or bleb revision 1 1.4 1 0.7 0.542
Lensectomya 3 7.7 2 2.9 0.352
Complications (later than 6 months)
Hypotony 9 13.4 14 9.7 0.421
Choroidal effusion/detachment 4 6.0 7 4.9 0.746
Uveitis 8 11.9 13 9.0 0.511
Bleb encapsulation 11 16.4 4 2.8 0.001*
Tube retraction 3 4.5 1 0.7 0.095
Corneal decompensation 8 11.9 22 15.3 0.518
Endophthalmitis 2 3.0 2 1.4 0.593
Retinal detachment 3 4.5 4 2.8 0.682
Cataracta 8 22.9 8 11.9 0.150
Postoperative procedures (later than 6 months)
Intracameral injection of viscoelastic 3 4.5 15 10.4 0.151
Tying tube off 7 10.4 8 5.6 0.250
Removal/adjustment of stent suture 21 31.3 49 34.0 0.700
Tube shortening/repositioning 21 31.3 15 10.4 <0.001*
Bleb needling or bleb revision 10 14.9 5 3.5 0.007*
Lensectomya 14 40.0 21 31.3 0.382
aOnly phakic patients included
Chi-square or Fisher’s exact test were used where appropriate
*Denotes statistical significance
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cases of sterile endophthalmitis. This discrepancy indicates
that pediatric eyes may be more prone to infection and also
reflects the inherent difficulties in postoperative management
of children, including their relatively poor adherence to post-
operative treatment and periocular hygiene rules. In addition,
frequent eye rubbing in childrenmay predispose these patients
to conjunctival dehiscence and tube exposure, which are
known risk factors for infection [18]. Conjunctival dehiscence
shortly after retinal detachment surgery may have actually
been the cause of endophthalmitis in one of our pediatric
cases. Careful and meticulous closure of the conjunctiva and
strict adherence to postoperative instructions are deemed im-
portant to reduce the risk of infection after GDD surgery.
Although antimetabolites reduce scar tissue formation, no
association was found between the use of MMC and bleb
encapsulation in this study. Furthermore, MMC was not found
to be associated with endophthalmitis in either age group.
However, these findings should be interpreted with caution due
to the limited statistical power of our study and the rather small
number of patients undergoing non-augmented GDD surgery.
Compared with adults, eye size in children can change
more significantly as a result of changes in eye pressure due
to the more elastic scleral tissue. Thus, any sustained increase
(as in uncontrolled glaucoma) or decrease (after GDD sur-
gery) in eye pressure can cause more significant changes in
the size of the pediatric eye; hence, tube position may change
more significantly in children. Moreover, the natural increase
in eye size as part of children’s growth may result in tube
retraction or a progressive change in the position of the intra-
ocular part of the tube relative to the cornea. This may explain
the observation that significantly more pediatric patients than
adults required tube shortening or repositioning in our study.
Although not statistically significant, adults developed cor-
neal decompensationmore frequently than children. There is no
direct comparison of corneal decompensation rates in adults
and children in the available literature; however, rates of persis-
tent corneal edema of up to 16% in adults [2] and up to 25% in
pediatric patients undergoing GDD surgery have been reported
[12]. Moreover, in our study, the cornea decompensated earlier
in the adult group, which may be attributed to the fact that adult
corneas may have fewer endothelial cells than children and,
thus, may be more vulnerable to tube-induced endothelial cell
loss. Although this hypothesis cannot be corroborated by spec-
ular microscopy data due to the retrospective nature of this
study, the authors feel that it is advisable that the surgeon en-
sures proper positioning of the tube away from the corneal
endothelium to minimise the risk of endothelial cell damage,
and, in fact, we observed improvement in localized corneal
edema after trimming or repositioning of tubes in certain cases.
Additionally, regularly checking the mobility of the intraocular
portion of the tube via pressure through the upper eyelid would
help detect those patients at risk of tube-cornea touch who
would benefit from further prophylactic tube shortening or
repositioning. These measures also count for children, especial-
ly those with corneal changes (Haab’s striae) as a result of
congenital glaucoma or chronic uveitis, who may also be at
higher risk for corneal decompensation. Another potential rea-
son for the relatively higher and quicker decompensation rate in
adults could be the longer duration of the glaucoma condition
suffered by adults and also the longer duration of glaucoma
medication used in this group that may have had a negative
impact on the health of corneal endothelium.
No proper cause for the slightly higher rate of cataract
formation in the pediatric group was identified. However, it
could be hypothesized that the more uncontrolled rubbing of
the eyes in this group may have caused frequent impact of the
tube against the anterior surface of the iris and the lens.
Furthermore, children might be more susceptible to the devel-
opment of lens opacities secondary to the long duration of
topical steroid use postoperatively.
Our findings should be evaluated under consideration of
the various limitations of the study. This was a retrospective,
non-randomized study with variable follow-up length, and
data retrieval was based on case notes; therefore, documenta-
tion bias cannot be excluded. Furthermore, post-hoc power
analysis showed that the sample size was not sufficiently large
to detect differences in the success/failure rates of GDD.
Despite these limitations, this is the first study directly
comparing GDD outcomes and complications in children versus
adults. The results presented here provide useful insight into
potentially different challenges in postoperative care.
Furthermore, patients came from the same population and were
operated upon by the same surgeon, thus eliminating any surgeon
and patient selection bias. Ideally, a prospective and adequately
powered study would clarify whether GDD surgery carries a
different prognosis in pediatric versus adult patients and whether
the observed postoperative disparities reflect inherent differences
in the surgical management of their glaucoma.
In summary, this comparative study showed that GDD
surgery may have similar outcomes but presents different
postoperative challenges in children and adults. This may be
related to the inherent differences in the nature of glaucoma
and eye characteristics between these groups. Hypotony
seems to be common in both age groups in the first 6 months
postoperatively but can be managed successfully in the
majority of cases. However, in the late postoperative period,
children may need bleb needling and tube repositioning more
frequently than adults due to their tendency for bleb encapsu-
lation and progressive anterior rotation of the intraocular
portion of the tube. Furthermore, it is of utmost importance
that the surgeon remains vigilant for signs of endophthalmitis
in pediatric patients, because the condition tends to occur
more frequently in pediatric as compared to adult patients
and may require early removal of the GDD. Adults may be
more prone to corneal decompensation, which also tends to
occur earlier than in children.
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